gamma-secretases: from cell biology to therapeutic strategies

Lancet Neurology
Bruno A Bergmans, Bart De Strooper

Abstract

Presenilins form the catalytic part of the gamma-secretases, protein complexes that are responsible for the intramembranous cleavage of transmembrane proteins. The presenilins are involved in several biological functions, but are best known for their role in the generation of the beta-amyloid (Abeta) peptide in Alzheimer's disease and are therefore thought to be important drug targets for this disorder. Mutations in the presenilin genes cause early-onset familial Alzheimer's disease, but mutation carriers have substantial phenotypic heterogeneity. Recent evidence implicating presenilin mutations in non-Alzheimer's dementias, including frontotemporal dementia and Lewy body dementia, warrants further investigation. An increased understanding of the diversity of the molecular cell biology of the gamma-secretase complex and the effects of clinical mutations in the presenilin genes might help pave the way for improved development of drugs that are designed to target gamma-secretase enzymatic activity in Alzheimer's disease and potentially in other neurological diseases.

References

Mar 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·W J StrittmatterA D Roses
Jul 1, 1996·Human Molecular Genetics·R SherringtonP H St George-Hyslop
Apr 1, 1998·American Journal of Epidemiology·A OttA Hofman
Apr 1, 1998·Human Mutation·M Cruts, C Van Broeckhoven
Jun 9, 1999·Proceedings of the National Academy of Sciences of the United States of America·W SongB A Yankner
Jan 25, 2000·Journal of Neurology, Neurosurgery, and Psychiatry·M YasudaC Tanaka
Nov 23, 2000·Genes & Development·R Kopan, A Goate
Jan 9, 2001·Journal of Neurochemistry·H F DoveyJ E Audia
Feb 24, 2001·Annals of Neurology·M J SmithW S Brooks
May 31, 2001·Journal of Neuropathology and Experimental Neurology·A VerkkoniemiM Haltia
Sep 19, 2001·Journal of Neurology, Neurosurgery, and Psychiatry·N SodeyamaY Komatsuzaki
Mar 29, 2002·American Journal of Medical Genetics·Miho Matsubara-TsutsuiTetsuro Miki
Jun 6, 2002·Proceedings of the National Academy of Sciences of the United States of America·Tobias MoehlmannHarald Steiner
Jun 22, 2002·The Cochrane Database of Systematic Reviews·N Tabet, H Feldman

❮ Previous
Next ❯

Citations

May 24, 2012·Acta Neuropathologica·Gerard D Schellenberg, Thomas J Montine
Oct 15, 2011·Journal of Medicinal Chemistry·Antonia F StepanR Scott Obach
Jun 2, 2012·Journal of Medicinal Chemistry·Francois BischoffHarrie J M Gijsen
Jul 29, 2010·Current Opinion in Neurology·Conrad C Weihl, Alan Pestronk
Nov 21, 2013·Acta Neuropathologica Communications·María-Salud García-AyllónJavier Sáez-Valero
May 10, 2013·PloS One·Yi PiaoToshiharu Suzuki
Nov 29, 2011·Yi chuan = Hereditas·Yu ZhangHong-Sheng Song
Nov 5, 2013·Biochimica Et Biophysica Acta·Weiqiang ZhouShanchun Guo
Apr 16, 2014·European Journal of Medicinal Chemistry·Yung-Feng LiaoMing-Kuan Hu
Apr 5, 2011·Annual Review of Neuroscience·Richard J O'Brien, Philip C Wong
Jul 3, 2015·Molecular Medicine Reports·Zeng-Zhang ZhengHong-Sheng Song
Oct 27, 2015·Journal of Cellular Physiology·Hany MareiThomas Caceci
May 26, 2012·Cellular Signalling·Sylvie ClaeysenPatrizia Giannoni
Jul 26, 2011·Science China. Life Sciences·Charlene Supnet, Ilya Bezprozvanny
Oct 21, 2015·The Journal of Experimental Medicine·Maria SzarugaLucía Chávez-Gutiérrez
Oct 26, 2012·The Journal of Investigative Dermatology·Andrew E PinkJonathan N W Barker
Dec 9, 2014·Cell Adhesion & Migration·Lakmali AtapattuPeter W Janes
Oct 12, 2010·Science·Baoxi WangXue Zhang
Aug 27, 2014·BioMed Research International·Gan-lin ZhangJin-Ping Li
Aug 1, 2015·Molecular Neurobiology·Shu-Lei LiuJin-Tai Yu
Dec 15, 2010·Bioorganic & Medicinal Chemistry·Prashi JainJeffry D Madura
Aug 11, 2016·BMC Neurology·Sonja SchöneckerAdrian Danek
Jan 15, 2011·Expert Opinion on Therapeutic Patents·Martin PetterssonDouglas S Johnson
May 17, 2017·Journal of Alzheimer's Disease : JAD·Jin-Bao ZhuJin-Tai Yu
Sep 20, 2015·Neurología : publicación oficial de la Sociedad Española de Neurología·S Rius-PérezR Taléns-Visconti
Oct 29, 2017·Biochemical Society Transactions·Aonghus J McCarthyJustin V McCarthy
Apr 17, 2012·The EMBO Journal·Lucía Chávez-GutiérrezBart De Strooper
Jun 13, 2018·Antioxidants & Redox Signaling·Elena PopugaevaIlya Bezprozvanny
Jun 5, 2012·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Cary EsselensWim Annaert
Jan 1, 2013·The Journal of Pharmacology and Experimental Therapeutics·Charles F AlbrightGary Tong
Sep 26, 2014·Cancer Investigation·Alessandro AllegraCaterina Musolino

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Alzheimer's Disease: Animal Models

Alzheimer's disease is a neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.